Mark G. Alexandrow
Affiliations: | Biology (Cell Biology, Microbiology, Molecular Biology) | University of South Florida, Tampa, FL, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Mark Alexandrow"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nepon-Sixt BS, Alexandrow MG. (2019) TGFβ1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-deficient Conditions Molecular Cancer Research. 17: 277-288 |
| Alexander LMM, Watters J, Reusch JA, et al. (2017) Data supporting the functional role of Eleven-nineteen Lysine-rich Leukemia 3 (ELL3) in B cell lymphoma cell line cells. Data in Brief. 15: 222-227 |
| Alexander LMM, Watters J, Reusch JA, et al. (2017) Selective expression of the transcription elongation factor ELL3 in B cells prior to ELL2 drives proliferation and survival. Molecular Immunology. 91: 8-16 |
| Leone A, Diorio G, Sexton W, et al. (2017) Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach. Oncotarget |
| Borysov SI, Nepon-Sixt BS, Alexandrow MG. (2015) The N-terminus of the Rb Protein Inhibits DNA Replication Via a Bipartite Mechanism Disrupted In Partially Penetrant Retinoblastomas. Molecular and Cellular Biology |
| Bryant VL, Elias RM, McCarthy SM, et al. (2015) Suppression of Reserve MCM Complexes Chemosensitizes to Gemcitabine and 5-Fluorouracil. Molecular Cancer Research : McR. 13: 1296-305 |
| Kumar NB, Quinn GP, Alexandrow MG, et al. (2014) Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer. Journal of Clinical Trials. 4 |
| Gray JE, Altiok S, Alexandrow MG, et al. (2013) Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer. 119: 1023-32 |
| Alexandrow MG, Song LJ, Altiok S, et al. (2012) Curcumin: a novel Stat3 pathway inhibitor for chemoprevention of lung cancer. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 21: 407-12 |
| Kumar NB, Quinn GP, Crocker T, et al. (2012) Assessment of feasibility and willingness of former heavy smokers to participate in chemoprevention trials to prevent lung cancer. Journal of Clinical Oncology. 30: e21155-e21155 |